Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07130396) titled 'Impact of Multivitamin (PhytoMulti(R)) and a Probiotic (UltraFlora(R) Balance Probiotic) on Gut Health of People Taking GLP-1 Medication' on Aug. 12.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Supportive Care. Masking: None (Open Label).
Primary Sponsor: Metagenics, Inc.
Condition:
GLP-1
Adults
Intervention:
Dietary Supplement: Multivitamin and a Probiotic
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: November 1, 2025
Target Sample Size: 100
To know more, visit https://clinicaltrials.gov/ct2/show/NCT0...